Digital

Insilico Medicine and MobiDrop Sign Strategic Partnership to Advance AI‑Ready Single‑Cell Data for Drug Discovery
AIHKG: 3696

Insilico Medicine and MobiDrop Sign Strategic Partnership to Advance AI‑Ready Single‑Cell Data for Drug Discovery

Insilico Medicine (HKG: 3696) signed a strategic cooperation agreement with MobiDrop, under which the two parties will engage in deep collaboration around the generation, integration, and application of high‑quality, traceable,…

Takeda and Ant Group Form Digital Healthcare Partnership to Advance AI‑Driven Patient Care in China

Takeda and Ant Group Form Digital Healthcare Partnership to Advance AI‑Driven Patient Care in China

METiS and WestVac Biopharma Forge AI Partnership to Develop Personalized mRNA Cancer Vaccines

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Contact US
Insilico Medicine Launches AI‑Powered Automated Partnering System – Transforms Biotech Business Development
AIHKG: 3696

Insilico Medicine Launches AI‑Powered Automated Partnering System – Transforms Biotech Business Development

AIClinical trial approval / initiation

ReviR Therapeutics Doses First Patient in RTX-117 Trial – China’s First “AI + RNA” Small Molecule Enters Clinic

Insilico Medicine Partners with MSKCC to Discover Gastroesophageal Cancer Targets – AI‑Driven Multi‑Omics Analysis
AICancer

Insilico Medicine Partners with MSKCC to Discover Gastroesophageal Cancer Targets – AI‑Driven Multi‑Omics Analysis

Takeda Enters $1.7 Billion AI Drug Discovery Partnership with Iambic Therapeutics
AIIambic Therapeutics

Takeda Enters $1.7 Billion AI Drug Discovery Partnership with Iambic Therapeutics

Show More